Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q7C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,500
Award facts
- Contract value 100% obligated
- $18,500.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,500.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Dupixent 300 mg/2 mL pen injectors. This non-set-aside competitive award is scheduled for completion by January 9, 2026, with performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability in fulfilling federal medical procurement requirements through open competition. The company's extensive portfolio includes brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic domains. This award of Dupixent—a specialty biologic medication used for conditions such as atopic dermatitis and eosinophilic asthma—reflects the contractor's continued role in supplying critical pharmaceutical commodities to support military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9Q7C?
SPE2DR26F9Q7C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F9Q7C worth?
The government has obligated $18,500 on SPE2DR26F9Q7C.
Is contract SPE2DR26F9Q7C an order under another contract?
Yes. SPE2DR26F9Q7C is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q7C competed?
The extent of competition for SPE2DR26F9Q7C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award